Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Respiratory bronchiolitis - interstitial lung disease is a mild inflammatory pulmonary disorder developed by cigarette smokers and characterized by shortness of breath and cough, pulmonary function abnormalities of mixed restrictive and obstructive lung disease and high resolution CT scanning showing centrilobular micronodules, ground glass opacities and peribronchiolar thickening.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for respiratory bronchiolitis-interstitial lung disease syndrome.
3 publications have been identified in PubMed for respiratory bronchiolitis-interstitial lung disease syndrome. Research spans Review / Meta-Analysis (67%) and Epidemiology / Natural History (33%).
Kang HK (2025). [PMID: 40081337](https://pubmed.ncbi.nlm.nih.gov/40081337/). *Tuberc Respir Dis (Seoul)*. [Review / Meta-Analysis]
De Rosa S (2025). [PMID: 41106425](https://pubmed.ncbi.nlm.nih.gov/41106425/). *Semin Respir Crit Care Med*. [Epidemiology / Natural History]
Agarwala P (2024). [PMID: 39536942](https://pubmed.ncbi.nlm.nih.gov/39536942/). *Semin Respir Crit Care Med*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:51 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center